Mount Vernon Associates Inc Bristol Myers Squibb CO Transaction History

Mount Vernon Associates Inc

$121 Million
Q3 2024

A detailed history of Mount Vernon Associates Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mount Vernon Associates Inc holds 30,879 shares of BMY stock, worth $1.8 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares

30,879

Previous 29,779 3.69%

Holding current value

$1.8 Million

Previous $1.24 Million 29.1%

% of portfolio

1.32%

Previous 1.1%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$39.66 - $51.75 $43,625 - $56,925	1,100 Added 3.69%	30,879 $1.6 Million
Q2 2024 Jul 19, 2024	BUY	$40.25 - $52.99 $6,440 - $8,478	160 Added 0.54%	29,779 $1.24 Million
Q1 2024 Apr 22, 2024	BUY	$47.98 - $54.4 $6,669 - $7,561	139 Added 0.47%	29,619 $1.61 Million
Q4 2023 Jan 26, 2024	BUY	$48.48 - $57.85 $96,960 - $115,700	2,000 Added 7.28%	29,480 $1.51 Million
Q3 2023 Oct 24, 2023	BUY	$57.89 - $64.73 $23,792 - $26,604	411 Added 1.52%	27,480 $1.6 Million
Q2 2023 Jul 24, 2023	BUY	$63.71 - $70.74 $17,520 - $19,453	275 Added 1.03%	27,069 $1.73 Million
Q1 2023 Apr 20, 2023	SELL	$65.71 - $74.53 $36,140 - $40,991	-550 Reduced 2.01%	26,794 $1.86 Million
Q3 2022 Oct 21, 2022	BUY	$0.13 - $76.84 $24 - $14,599	190 Added 0.7%	27,344 $1.94 Million
Q1 2022 Apr 25, 2022	BUY	$61.48 - $73.72 $23,055 - $27,645	375 Added 1.4%	27,154 $1.98 Million
Q4 2021 Jan 25, 2022	BUY	$53.63 - $62.52 $8,044 - $9,378	150 Added 0.56%	26,779 $1.67 Million
Q3 2021 Oct 20, 2021	BUY	$59.17 - $69.31 $11,834 - $13,862	200 Added 0.76%	26,629 $1.58 Million
Q4 2020 Jan 25, 2021	BUY	$57.74 - $65.43 $5,774 - $6,543	100 Added 0.38%	26,429 $1.64 Million
Q3 2020 Oct 23, 2020	SELL	$57.43 - $63.64 $14,357 - $15,910	-250 Reduced 0.94%	26,329 $1.59 Million
Q2 2020 Jul 27, 2020	SELL	$54.82 - $64.09 $7,236 - $8,459	-132 Reduced 0.49%	26,579 $1.56 Million
Q1 2020 Apr 23, 2020	BUY	$46.4 - $67.43 $38,651 - $56,169	833 Added 3.22%	26,711 $1.49 Million
Q4 2019 Jan 24, 2020	SELL	$49.21 - $64.19 $7,381 - $9,628	-150 Reduced 0.58%	25,878 $1.66 Million
Q3 2019 Oct 16, 2019	SELL	$42.77 - $50.71 $17,108 - $20,284	-400 Reduced 1.51%	26,028 $1.32 Million
Q2 2019 Jul 30, 2019	SELL	$44.62 - $49.34 $955,314 - $1.06 Million	-21,410 Reduced 44.76%	26,428 $1.2 Million
Q2 2019 Jul 25, 2019	BUY	$44.62 - $49.34 $955,314 - $1.06 Million	21,410 Added 81.01%	47,838 $2.17 Million
Q1 2019 Apr 25, 2019	SELL	$45.12 - $53.8 $7,128 - $8,500	-158 Reduced 0.59%	26,428 $1.26 Million
Q4 2018 Jan 24, 2019	SELL	$48.76 - $63.23 $39,008 - $50,584	-800 Reduced 2.92%	26,586 $1.38 Million
Q3 2018 Oct 22, 2018	BUY	$55.19 - $62.25 $2,373 - $2,676	43 Added 0.16%	27,386 $1.7 Million
Q2 2018 Jul 27, 2018	SELL	$50.53 - $62.98 $80,848 - $100,768	-1,600 Reduced 5.53%	27,343 $1.51 Million
Q1 2018 Apr 19, 2018	SELL	$59.92 - $68.98 $23,968 - $27,592	-400 Reduced 1.36%	28,943 $1.83 Million
Q3 2017 Oct 24, 2017	BUY	$55.23 - $63.74 $1.62 Million - $1.87 Million	29,343	29,343 $1.87 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mount Vernon Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mount Vernon Associates Inc with notifications on news.

Account

Mount Vernon Associates Inc Bristol Myers Squibb CO Transaction History